Bioxytran, Inc.
BIXT
$0.04
$0.000.84%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 10.29% | 11.02% | 28.87% | 25.62% | 47.09% |
| Total Depreciation and Amortization | 45.57% | 30.68% | -3.30% | -20.41% | -4.82% |
| Total Amortization of Deferred Charges | -- | 1,032.36% | 2,059.33% | 94.43% | 94.43% |
| Total Other Non-Cash Items | 207.98% | -52.89% | -63.45% | -5.64% | 39.05% |
| Change in Net Operating Assets | -10.48% | -39.90% | -48.05% | -43.44% | -65.43% |
| Cash from Operations | -38.08% | -20.64% | 26.94% | 37.12% | 50.83% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 18.09% | -27.75% | -54.88% | 51.32% | 36.34% |
| Cash from Investing | 18.09% | -27.75% | -54.88% | 51.32% | 36.34% |
| Total Debt Issued | -0.77% | 91.91% | 335.31% | 294.57% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 596.83% | -87.59% | -100.00% | -88.55% | -88.55% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 171.28% | 31.88% | -21.53% | -24.05% | -29.40% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,515.31% | 55.92% | 67.51% | 96.11% | 92.24% |